Ameliorating effects of sulfonylurea drugs on insulin resistance in Otsuka Long-Evans Tokushima Fatty Rats

Korean Journal of Physiology and Pharmacology

Volumn 12, Issue 1, 2008, Pages 7-12

  Park, Jeong Kwon ^a   Kim, Sang Pyo ^a   Song, Dae Kyu ^a  

^a Keimyung University School of Medicine   (South Korea)

Author keywords

Diabetic rat; Glucose transporters; KA'T'P channel; Sulfonylureas

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM); GLICLAZIDE; GLIMEPIRIDE; GLUCOSE TRANSPORTER 2; GLUCOSE TRANSPORTER 4; INSULIN RECEPTOR; INSULIN RECEPTOR BETA; INWARDLY RECTIFYING POTASSIUM CHANNEL SUBUNIT KIR6.2; REPAGLINIDE; UNCLASSIFIED DRUG;

ADIPOSE TISSUE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG MECHANISM; DRUG POTENCY; GLUCOSE TOLERANCE TEST; IMMUNOFLUORESCENCE TEST; IMMUNOHISTOCHEMISTRY; INSULIN RESISTANCE; INSULIN SENSITIVITY; MALE; MUSCLE TISSUE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PROTEIN EXPRESSION; RAT;

EID: 40749086741     PISSN: 12264512     EISSN: None     Source Type: Journal    
DOI: 10.4196/kjpp.2008.12.1.7     Document Type: Article

References (27)

1. Abel ED, Peroni O, Kim JK, Kim YB, Boss O, Hadro E, Minnemann T, Shulman GI, Kahn BB. Adipose-selective targeting of the GLUT4 gene impairs insulin action in muscle and liver. Nature 409: 729-733, 2001
2. Ashcroft FM. ATP-sensitive potassium channelopathies: focus on insulin secretion. J Clin Invest 115: 2047-2058, 2005
3. Bajaj M, Defronzo RA. Metabolic and molecular basis of insulin resistance. J Nucl Cardiol 10: 311-323, 2003
4. Boyd JJ, Contreras I, Kern M, Tapscott EB, Downes DL, Frisell WR, Dohm GL. Effect of a high-fat-sucrose diet on in vivo insulin receptor kinase activation. Am J Physiol 259: E111-116, 1990
5. Eisenberg ML, Maker AV, Slezak LA, Nathan JD, Sritharan KC, Jena BP, Geibel JP, Andersen DK. Insulin receptor (IR) and glucose transporter 2 (GLUT2) proteins form a complex on the rat hepatocyte membrane. Cell Physiol Biochem 15: 51-58, 2005
6. Handberg A, Vaag A, Damsbo P, Beck-Nielsen H, Vinten J. Expression of insulin regulatable glucose transporters in skeletal muscle from type 2 (non-insulin-dependent) diabetic patients. Diabetologia 33: 625-627, 1990
7. Hughes VA, Fiatarone MA, Fielding RA, Kahn BB, Ferrara CM, Shepherd P, Fisher EC, Wolfe RR, Elahi D, Evans WJ. Exercise increases muscle GLUT-4 levels and insulin action in subjects with impaired glucose tolerance. Am J Physiol 264: E855-862, 1993
8. Kahn BB. Lilly lecture 1995. Glucose transport: pivotal step in insulin action. Diabetes 45: 1644-1654, 1996
9. Kawamori R, Morishima T, Kubota M, Matsuhisa M, Ikeda M, Kamada T. Influence of oral sulfonylurea agents on hepatic glucose uptake. Diabetes Res Clin Pract 28 Suppl: S109-113, 1995
10. Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T. Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41: 1422-1428, 1992
11. Kern PA, Saghizadeh M, Ong JM, Bosch RJ, Deem R, Simsolo RB. The expression of tumor necrosis factor in human adipose tissue. Regulation by obesity, weight loss, and relationship to lipoprotein lipase. J Clin Invest 95: 2111-2119, 1995
12. Koike T, Tomoda F, Kinuno H, Inoue H, Takata M. Abnormal renal structural alterations during the development of diabetes mellitus in Otsuka Long-Evans Tokushima Fatty rats. Acta Physiol Scand 184: 73-81, 2005
13. Kumar N, Dey CS. Gliclazide increases insulin receptor tyrosine phosphorylation but not p38 phosphorylation in insulin-resistant skeletal muscle cells. J Exp Biol 205: 3739-3746, 2002
14. Lebovitz HE, Feinglos MN, Bucholtz HK, Lebovitz FL. Potentiation of insulin action: a probable mechanism for the anti-diabetic action of sulfonylurea drugs. J Clin Endocrinol Metab 45: 601-604, 1977
15. Marin P, Rebuffe-Scrive M, Smith U, Bjorntorp P. Glucose uptake in human adipose tissue. Metabolism 36: 1154-1160, 1987
16. ATP channel-deficient mice. Proc Natl Acad Sci U S A 95: 10402-10406, 1998
17. + channel-mediated glucose uptake is independent of IRS-1/phosphatidylinositol 3-kinase signaling. Am J Physiol Endocrinol Metab 285: E1289-1296, 2003
18. Mori Y, Komiya H, Kurokawa N, Tajima N. Comparison of the effects of glimepiride and glibenclamide on adipose tissue tumour necrosis factor-alpha mRNA expression and cellularity. Diabetes Obes Metab 6: 28-34, 2004
19. Muller G, Satoh Y, Geisen K. Extrapancreatic effects of sulfonylureas-a comparison between glimepiride and conventional sulfonylureas. Diabetes Res Clin Pract 28 Suppl: S115-137, 1995
20. Pedersen O, Bak JF, Andersen PH, Lund S, Moller DE, Flier JS, Kahn BB. Evidence against altered expression of GLUT1 or GLUT4 in skeletal muscle of patients with obesity or NIDDM. Diabetes 39: 865-870, 1990
21. Rodriguez E, Pulido N, Romero R, Arrieta F, Panadero A, Rovira A. Phosphatidylinositol 3-kinase activation is required for sulfonylurea stimulation of glucose transport in rat skeletal muscle. Endocrinology 145: 679-685, 2004
22. Proks P, Reimann F, Green N, Gribble F, Ashcroft F. Sulfonylurea stimulation of insulin secretion. Diabetes 51 Suppl 3: S368-376, 2002
23. Schernthaner G, Grimaldi A, Di Mario U, Drzewoski J, Kempler P, Kvapil M, Novials A, Rottiers R, Rutten GE, Shaw KM. GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients. Eur J Clin Invest 34: 535-542, 2004
24. Toide K, Man ZW, Asahi Y, Sato T, Nakayama N, Noma Y, Oka Y, Shims K. Glucose transporter levels in a male spontaneous non-insulin-dependent diabetes mellitus rat of the Otsuka Long-Evans Tokushima Fatty strain. Diabetes Res Clin Pract 38: 151-160, 1997
25. UKPDS. Intensive blood-glucose control with sulfonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group. Lancet 352: 837-853, 1998
26. Wang R, Liu X, Hentges ST, Dunn-Meynell AA, Levin BE, Wang W, Routh VH. The regulation of glucose-excited neurons in the hypothalamic arcuate nucleus by glucose and feeding-relevant peptides. Diabetes 53: 1959-1965, 2004
27. Wasada T, Yano T, Ohta M, Yui N, Iwamoto Y. ATP-Sensitive potassium channels modulate glucose transport in cultured human skeletal muscle cells. Endocr J 48: 369-375, 2001